Edition:
United Kingdom

People: Accelerate Diagnostics Inc (AXDX.OQ)

AXDX.OQ on NASDAQ Stock Exchange Capital Market

19.12USD
16 Jul 2019
Change (% chg)

-- (--)
Prev Close
$19.12
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
71,810
52-wk High
$24.70
52-wk Low
$10.25

Mehren, Lawrence 

Mr. Lawrence Mehren is President, Chief Executive Officer, Director of Accelerate Diagnostics Inc. since June 26, 2012. Mr. Mehren served as Senior Vice President and Chief Financial Officer of Ventana Medical Systems from 2007 until 2008, SVP of Emerging Businesses from 2008 until 2009, and as Head of Global Business from 2009 until 2011. Previously, he was Managing Director, Partner and head of P&M Corporate Finance’s (an investment banking firm based in Detroit, Michigan) life sciences practice. Prior to his tenure at P&M, Mr. Mehren worked in management positions with Gale Group, a division of The Thomson Corporation, as well as Merrill Lynch. Mr. Mehren holds a B.A. in Political Science from the University of Arizona and an M.B.A. from Northwestern University’s Kellogg Graduate School of Management.

Basic Compensation

Total Annual Compensation, USD 375,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 375,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Patience

161,802

Lawrence Mehren

375,000

Steve Reichling

694,800

Ron Price

871,188

Thomas Brown

767,025

Mark Miller

161,802
As Of  31 Dec 2017